1.Sustainability of Korean National Health Insurance.
Myoung Sheen KANG ; Hoo Sun JANG ; Minjee LEE ; Eun Cheol PARK
Journal of Korean Medical Science 2012;27(Suppl):S21-S24
Korean National Health Insurance (NHI) was established during only 12 yr from its inception (1977-1989), providing universal medical coverage to the entire nation and making a huge contribution to medical security. However, the program now faces many challenges in terms of sustainability. The low birth rates, aging population, low economic growth, and escalating demands for welfare, as well as unification issues, all add pressure to the sustainability of NHI. The old paradigm of low contribution - low benefits coverage - low NHI's fee schedule needs to be replaced by a new paradigm of proper contribution - adequate benefit coverage - fair NHI's fee schedule. This new paradigm will require reform of NHI's operating system, funding, and spending.
Health Care Reform
;
Humans
;
National Health Programs/*economics
;
Program Evaluation
;
Republic of Korea
;
Risk Factors
;
Universal Coverage/economics
2.Clinical and Laboratory Factors Associated with Symptom Development in Asymptomatic COVID-19 Patients at the Time of Diagnosis
Hong Sang OH ; Joon Ho KIM ; Myoung Lyeol WOO ; Ji-Yeon KIM ; Chul Hee PARK ; Hyejin WON ; Seungkwan LIM ; Hyeonju JEONG ; Sin Young HAM ; Eun Jin KIM ; Seungsoo SHEEN ; Yu Min KANG ; Doran YOON ; Seung Youp LEE ; Kyoung-Ho SONG
Infection and Chemotherapy 2021;53(4):786-791
In preparation for the surge of coronavirus disease 2019 (COVID-19), it is crucial to allocate medical resources efficiently for distinguishing people who remain asymptomatic until the end of the disease. Between January 27, 2020, and April 21, 2020, 517 COVID-19 cases from 13 healthcare facilities in Gyeonggi province, Korea, were identified out of which the epidemiologic and clinical information of 66 asymptomatic patients at the time of diagnosis were analyzed retrospectively. An exposure-diagnosis interval within 7 days and abnormal aspartate aminotransferase levels were identified as characteristic symptom development in asymptomatic COVID-19 patients. If asymptomatic patients without these characteristics at the time of diagnosis could be differentiated early, more medical resources could be secured for mild or moderate cases in this COVID-19 surge.